You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immunomodulator

Showing 26 - 50 of 290
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment Trial in Shanghai (NeoPep Vaccine1 plus Poly-ICLC, NeoPep

Recruiting
  • Glioma, Malignant
  • +2 more
  • NeoPep Vaccine1 plus Poly-ICLC
  • NeoPep Vaccine2 plus Poly-ICLC
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
Oct 7, 2022

COVID-19 Trial in Yogyakarta, Kota Jkt Utara (AD17002 + Formulation buffer, Placebo)

Not yet recruiting
  • COVID-19
  • AD17002 + Formulation buffer
  • Placebo
  • Yogyakarta, Daerah Istimewa Yogyakarta, Indonesia
  • +2 more
Sep 13, 2022

COVID-19 Vaccine Response in Chronic Respiratory Conditions

Recruiting
  • SARS-CoV Infection
  • COVID-19 vaccine
  • Denver, Colorado
    National Jewish Health
Apr 4, 2022

HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive

Recruiting
  • Drug Monitoring
  • Inflammatory Bowel Diseases
  • Tumor necrosis factor (TNF)-alpha inhibitors
  • Valladolid, Spain
    Hospital Universitario Rio Hortega
Aug 8, 2023

Necrotizing Enterocolitis Trial in San Fernando (Melatonin 6 MG, Breast Milk)

Recruiting
  • Necrotizing Enterocolitis
  • Melatonin 6 MG
  • Breast Milk
  • San Fernando, LA Union, Philippines
    Ilocos Training and Regional Medical Center
Dec 1, 2021

Cognitive Impairment, Mild, Cognitive Dysfunction, Amyloid Plaque Trial in Phoenix, Las Vegas (Lenalidomide 10 mg, Placebo)

Recruiting
  • Cognitive Impairment, Mild
  • +4 more
  • Lenalidomide 10 mg
  • Placebo
  • Phoenix, Arizona
  • +1 more
Apr 14, 2022

COVID19 Vaccination in Immunodeficient Patients

Active, not recruiting
  • Multiple Sclerosis
  • +2 more
  • COVID19 vaccine
  • New Haven, Connecticut
    Yale University
May 9, 2022

Dermatologic Disease Trial in Tanta (Tacrolimus ointment, Hydrocortisone 1% cream)

Recruiting
  • Dermatologic Disease
  • Tacrolimus ointment
  • Hydrocortisone 1% cream
  • Tanta, Egypt
    Tanta Unuversity
Nov 2, 2022

Immune Thrombocytopenia Trial (VIT D)

Not yet recruiting
  • Immune Thrombocytopenia
  • VIT D
  • (no location specified)
Oct 5, 2023

Sjogren's Syndrome Trial in Worldwide (Placebo, Nipocalimab, Standard of Care Treatment)

Recruiting
  • Sjogren's Syndrome
  • Placebo
  • +2 more
  • Anniston, Alabama
  • +77 more
Aug 18, 2022

Systemic Lupus Erythematosus Trial in Yantai (Placebo plus standard therapy, RC18 160 mg plus standard therapy)

Active, not recruiting
  • Systemic Lupus Erythematosus
  • Placebo plus standard therapy
  • RC18 160 mg plus standard therapy
  • Yantai, Shandong, China
    Remegen，ltd.
Jan 7, 2022

Dermatomyositis Trial in Nanchang (Lenalidomide)

Not yet recruiting
  • Dermatomyositis
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Aug 3, 2022

Disinfectant Causing Toxic Effect Trial (Alcohol sterilization, Honey sterilization)

Not yet recruiting
  • Disinfectant Causing Toxic Effect
  • Alcohol sterilization
  • Honey sterilization
  • (no location specified)
Jul 6, 2023

Dengue Fever With Warning Signs Trial (Melatonin 20 MG)

Not yet recruiting
  • Dengue Fever With Warning Signs
  • Melatonin 20 MG
  • (no location specified)
Oct 12, 2021

Eosinophilic Asthma Trial in Taipei (AD17002, Placebo)

Not yet recruiting
  • Eosinophilic Asthma
  • Taipei, Taiwan
    Taipei Medical University Hospital
Aug 16, 2023

Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in China, Taiwan (TJ202 and Dexamethasone)

Active, not recruiting
  • Multiple Myeloma in Relapse
  • Refractory Multiple Myeloma
  • TJ202 and Dexamethasone
  • Beijing, Beijing, China
  • +17 more
Oct 17, 2022

Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Hamburg, Germany
  • +3 more
Dec 16, 2022

Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome
  • Strasbourg, Bajo Rin, France
  • +24 more
Nov 22, 2021

Nigella Sativa Oil as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia Trial (Nigella Sativa Oil capsule)

Not yet recruiting
  • Nigella Sativa Oil as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia
  • Nigella Sativa Oil capsule
  • (no location specified)
Jul 11, 2023

Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)

Recruiting
  • Lymphoma
  • +3 more
  • New York, New York
    Columbia University
Apr 27, 2022

First Manifestation of Steroid Sensitive Nephrotic Syndrome Trial in Paris (Levamisole Hydrochloride, Placebo)

Completed
  • First Manifestation of Steroid Sensitive Nephrotic Syndrome
  • Levamisole Hydrochloride
  • Placebo
  • Paris, France
    Hôpital Robert Debré
Jun 7, 2022

Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)

Terminated
  • Hepatitis B, Chronic
  • Granulocyte Macrophage-colony Stimulating Factor
  • Entecavir
  • Beijing, Beijing, China
    302 Military Hospital
Mar 9, 2022

Vernal Keratoconjunctivitis, Cyclosporine 0.05% Eye Drops Trial in Nanchang (Cyclosporine 0.05% eye drops, Loteprednol Etabonate

Completed
  • Vernal Keratoconjunctivitis
  • Cyclosporine 0.05% Eye Drops
  • Cyclosporine 0.05% eye drops
  • Loteprednol Etabonate 0.5% and Tobramycin Eye Drops 0.3%
  • Nanchang, Jiangxi, China
    the Second Affiliated Hospital of Nanchang University
Apr 28, 2022

Uncomplicated Plasmodium Falciparum Trial in Tambolaka (Dihydroartemisinin, Piperaquine, Primaquine)

Completed
  • Uncomplicated Plasmodium Falciparum
  • Tambolaka, East Nusa Tenggara, Indonesia
    Kori Puskesmas
Apr 27, 2023

Unresectable Melanoma Trial in Pittsburgh (Nivolumab, Duvelisib)

Recruiting
  • Unresectable Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Apr 19, 2022